TFRC and Hepatic fibrosis: Isoliquiritigenin can inhibit the expression of GPX4 and increase the expression of TFR and divalent metal ion transporter 1, produce a large amount of ROS, induce HSCs ferroptosis, and alleviate liver fibrosis [40].